January 2024 - Page 5 of 7 - NetworkNewsWire

ThursdayJan 11, 2024 9:00 am

Mountain Top Properties Inc. (MTPP) Signs Master Lease for Exclusive Mixed-Use Property, Moves Forward with Hamptons Acquisitions

MTPP diversifies investment portfolio with projects spanning traditional property management, real estate development, and investments in PropTech Company recently secured lucrative lease for exclusive mixed-use property covering five acres in strategic Pennsylvania location MTPP builds, acquires, renovates, and remarkets waterfront/water-view properties in booming Hamptons amid skyrocketing demand and severe supply shortage Company currently raising $10 million in equity through a Reg A for Hamptons projects, secured debt capital commitments covering 70% of acquisition costs and 100% of construction expenses Diversification is critical for generating stable, above-average returns in today’s turbulent property market. With that goal in mind, Mountain Top Properties…

WednesdayJan 10, 2024 9:45 am

DGE’s 3rd Rx-to-OTC Switch Addresses the Various Considerations Involved in Transitioning Prescription Drugs to Nonprescription OTC Status

Professionals and executives specializing in Rx-to-OTC switch, regulatory affairs, brand marketing, and medical affairs are all invited to attend DGE’s 3rd Rx-to-OTC Switch being held in Philadelphia February 26-27, 2024. This summit aims to educate switch teams to design strategies to guarantee a successful switch, analyze new regulations surrounding ACNU, discuss the impact of e-commerce on OTC products, and navigate potential marketing challenges between health care professionals and consumers. This conference is hosted by Dynamic Global Events, a leading event company that organizes B2B conferences for healthcare organizations. This platform is a viable forum for education, discussion, and interaction among…

WednesdayJan 10, 2024 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Collaborates on Quantum Proof-of-Concept Project to Further Sustainable Building Design

The collaboration by VINCI Energies/DIANE, uptownBasel/ QuantumBasel, and D-Wave is an important step in sustainable building design Quantum-hybrid solution identified stronger HVAC network designs, outperforming the existing data-driven method D-Wave showcases the real-life impact of quantum computing through its client success stories, demonstrating the power of practical quantum computing today A quantum proof of concept (“qPoC”) project has taken an important step in sustainable building design. The collaboration, spearheaded by VINCI Energies/DIANE, uptownBasel/QuantumBasel, and D-Wave Quantum (NYSE: QBTS) is focused on optimizing the design of heating, ventilation, and air conditioning (“HVAC”) systems for complex buildings (https://nnw.fm/KYweA). The project's first phase…

WednesdayJan 10, 2024 9:00 am

GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons

NetworkNewsWire Editorial Coverage: On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type 2 diabetes (T2D). However, it wasn't just a milestone for T2D management. It was a turning point in medicine, opening the floodgates to a universe of potential therapeutic applications for this remarkable molecule. While undeniably transformative for diabetes and weight loss, GLP-1's reach now extends far beyond, likely surpassing even the wildest dreams of its creators. From Alzheimer's and Parkinson's to drug addiction, clinical trials are painting a stunning picture of GLP-1's…

TuesdayJan 09, 2024 9:00 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Finishes Demo Plant Commissioning for REE Processing, Turns to DOD Project and Commercial Facility Build-up

Canadian metals supply company Ucore Rare Metals Inc. recently announced completion of the third and final stage of its Demonstration Plant commissioning process for the separation of critical rare earth element (“REE”) metals used in various important technologies The commissioning process is a key part of the company’s demonstration of its proprietary RapidSX(TM) REE processing technology as it prepares for commercial production Ucore is at the forefront of companies attempting to break China’s virtual monopoly on REE production and separation processes by developing American-based supply chain solutions The company will now focus on proving its RapidSX(TM) technology in response to…

TuesdayJan 09, 2024 9:00 am

Mona & Frens – Web3 Is A Joke, Comes To San Francisco January 2024

In collaboration with Boonoob, Canopy and Mediacy Global (media sponsor), Web3 is a Joke brings you the comedy roast event Web3 is a Joke in San Francisco. The event will be hosted by founder Mona Shaikh, a seasoned comedian who has been featured on CNN, Forbes, and MSNBC. Mona and her team of comic entertainers present the epic comedy evening on Friday, January 26, 2024, at Canopy Jackson Square, 595 Pacific Ave 4th Floor, San Francisco, CA. Web3 Is A Joke is a Web3 comedy roast show known for its laugh-learn-link style. The comedians present important learning topics of Web3…

MondayJan 08, 2024 11:15 am

Astrotech Corp. (NASDAQ: ASTC) Announces New Mass Spectrometry Technology Application for Chemical Manufacturing and Introduces the Pro-Control Subsidiary

Astrotech’s newest subsidiary, Pro-Control, will use the company’s mass spectrometer technology to improve purity, and yields of distilled chemicals Pro-Control delivers value by improving lost yields and delivering found profits directly to the bottom line with little, which the company believes will lead to an overall increase in profitability Astrotech believes that the Pro-Control MVP has the ability to routinely improve yields from 20% to 30% The company is introducing its proprietary ATi Mass Spectrometer Technology into the vast chemical manufacturing and process control markets Astrotech (NASDAQ: ASTC), is an instrumentation company that is focused on commercializing its proprietary ATi…

MondayJan 08, 2024 10:30 am

Correlate Energy Corp. (CIPI) Marks Successful Close to the Year with Commissioning of ATD’s Huntersville Headquarters Solar Project

Correlate Energy, a distributed energy solutions company, just announced the successful commissioning of another solar project, this one located in ATD’s Huntersville headquarters The anticipated benefits for ATD go beyond environmental gains and into the expected generation of substantial cost savings by reducing reliance on traditional energy sources ATD’s solar power project follows Continental Envelope’s rooftop solar installation announced earlier Correlate Energy (OTCQB: CIPI), successfully capitalizing on the continued corporate push for financially positive decentralized energy generation, just announced the successful commissioning a major solar project located in American Tire Distributors’ (“ATD”) Huntersville, North Carolina headquarters. This follows the successful…

MondayJan 08, 2024 9:45 am

Turbo Energy (NASDAQ: TURB) Strategically Positioned for Growth in the Age of Artificial Intelligence

Despite challenges in the self-consumption photovoltaic sector, Turbo Energy achieved remarkable milestones, including the launch of the SunBox Industry product line, securing a patent, and forming strategic partnerships The company raised $5 million through its American Depositary Shares on the Nasdaq Capital Market, demonstrating its financial prowess amid industry headwinds Despite industry challenges, Turbo Energy maintains an optimistic outlook, leveraging diverse product offerings based on AI-driven energy optimization In the midst of challenges faced by the self-consumption photovoltaic sector in 2023, Turbo Energy (NASDAQ: TURB), a Spain-based photovoltaic energy storage innovator, achieved notable achievements. Despite revenue decline due to headwinds…

MondayJan 08, 2024 9:00 am

Sigyn Therapeutics Inc. (SIGY) Is ‘One to Watch’

Sigyn Therapeutics in May 2023 announced patent and trademark applications for its ImmunePrep commercialization platform In October 2022, the company announced patent and trademark applications for ChemoPrep and ChemoPure to enhance chemotherapy and reduce toxicity Sigyn Therapeutics in September 2022 announced plans to conduct first-in-human feasibility studies in end-stage renal disease patients In August 2022, the company commenced trading on the OTCQB Venture Market Sigyn Therapeutics (OTCQB: SIGY) is a development-stage medical technology company headquartered in San Diego, California. The company’s therapeutic candidates include Sigyn Therapy(TM) to address pathogen-associated inflammatory disorders, the ImmunePrep(TM) platform to enhance the performance of immunotherapeutic…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: January 2024